Loncar China BioPharma ETF (CHNA) ETF

Expense Ratio: 0.79% | AUM: 3.20M | Issuer: Exchange Traded Concepts

CHNA Daily Price Range
CHNA 52-Week Price Range

CHNA - Real-Time SMART Grade™

NR
Not Rated

Overall SMART Grade

CHNA has a real-time SMART Grade of NR (Not Rated).

Learn More About SMART Grades™

CHNA - Profile & Info


The investment objective of the Loncar China BioPharma ETF seeks to track an index built by Loncar that measures the performance of Chinese pharmaceutical and biotech companies. The index gets going by sifting out every biotech and pharma company listed on Nasdaq or the Hong Kong Stock Exchange. Companies that fall within those sectors in Loncar’s judgment are then “screened to eliminate those that focus strictly on manufacturing active pharmaceutical ingredients".

Issuer Exchange Traded Concepts
Expense Ratio 0.79%
Assets Under Management (AUM) 3.20M
Underlying Index LCHINA index
Asset Class Equity
ETF Category China Equities ETFs
Net Asset Value (NAV) $21.30
Options? Yes
Total Holdings 31

CHNA - Top Holdings

Symbol Holding Name % of Total

CHNA - Top Stories


View All CHNA News

CHNA - Price/Volume Stats

Current price $21.26
Prev. close $21.36
Day low $21.26
Day high $21.32
52-week high $25.92
52-week low $17.87
Day Volume 200
Avg. volume 2,556
Dividend yield 0.00%

CHNA - Recent Returns

1-mo -4.31%
3-mo -10.69%
6-mo 8.80%
1-year N/A
3-year N/A
5-year N/A
YTD 10.84%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

CHNA - Stock Chart


CHNA - Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular Articles



Page generated in 1.0416 seconds.